Design Therapeutics
DSGN
$4.05
Share price
2.79%
Change (1 day)
-25.41%
Change (1 year)
Categories
Design Therapeutics (DSGN) - Cash on Hand
Cash on Hand as of March 2024 : $0.27 B
According to Design Therapeutics's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Design Therapeutics - Cash on Hand chart (from 2020 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.33 B | -13.98% |
| 2021-12-31 | $0.38 B | 964.15% |
| 2020-12-31 | $36.09 M | 46771.43% |
| 2019-12-31 | $0.07 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.31 B | 17.03% | 🇺🇸 USA |